Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:41 pm Sale | 2025-06-30 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Anson Funds Management LP | 576,482 4.900% | -19,237 (-3.23%) | Filing History |
| 2025-08-14 6:45 pm Sale | 2025-08-14 | 13G | Hepion Pharmaceuticals, Inc. HEPA | S.H.N. Financial Investments Ltd. | 0 0.000% | -21,218 (Position Closed) | Filing History |
| 2025-05-15 5:23 pm Purchase | 2025-03-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Anson Funds Management LP | 595,719 9.900% | 595,538 (+328311.63%) | Filing History |
| 2025-01-27 4:15 pm Purchase | 2025-01-22 | 13G | Hepion Pharmaceuticals, Inc. HEPA | S.H.N. Financial Investments Ltd. | 21,218 9.990% | 21,218 (New Position) | Filing History |
| 2025-01-24 8:32 pm Purchase | 2025-01-21 | 13G | Hepion Pharmaceuticals, Inc. HEPA | BIGGER CAPITAL FUND L P | 21,218 9.990% | 21,218 (New Position) | Filing History |
| 2024-11-14 4:07 pm Sale | 2024-09-30 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Armistice Capital, LLC | 6,091 4.990% | -2,269 (-27.14%) | Filing History |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Armistice Capital, LLC | 8,360 8.670% | 8,360 (New Position) | Filing History |
| 2022-02-14 06:05 am Sale | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Altium Capital Management LLC | 0 0.000% | -4,500 (Position Closed) | Filing History |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | VANGUARD GROUP INC | 3,326 4.360% | 1,597 (+92.41%) | Filing History |
| 2022-01-19 10:48 am Sale | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management, LP | 336 0.440% | -3,664 (-91.61%) | Filing History |
| 2022-01-03 5:57 pm Sale | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | SABBY MANAGEMENT LLC | 604 11.000% | -4,396 (-87.92%) | Filing History |
| 2021-02-24 10:46 am Purchase | 2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Altium Capital Management LLC | 4,500 5.900% | 4,500 (New Position) | Filing History |
| 2021-02-19 2:45 pm Purchase | 2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA | SABBY MANAGEMENT LLC | 5,000 11.000% | 4,417 (+757.14%) | Filing History |
| 2021-02-18 10:49 am Purchase | 2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management, LP | 4,000 5.250% | 3,664 (+1091.38%) | Filing History |
| 2021-02-16 09:59 am Purchase | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | CVI Investments, Inc. | 420 1.300% | 420 (New Position) | Filing History |
| 2021-02-10 10:57 am Purchase | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | VANGUARD GROUP INC | 1,729 5.960% | 1,729 (New Position) | Filing History |
| 2021-02-09 3:50 pm Purchase | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Hudson Bay Capital Management LP | 296 0.920% | 2 (+0.76%) | Filing History |
| 2021-01-20 11:10 am Sale | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management, LP | 336 1.050% | -1,664 (-83.21%) | Filing History |
| 2021-01-07 1:38 pm Sale | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | SABBY MANAGEMENT LLC | 583 11.000% | -1,417 (-70.84%) | Filing History |
| 2020-12-28 4:57 pm Sale | 2020-12-23 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Orin Hirschman | 1,173 4.000% | -827 (-41.34%) | Filing History |